Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO ...

Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Ladies and gentlemen, thank you for standing by. At this time, I ...

Discover insights from Cytek Biosciences' Q2 2025 earnings call. Learn about revenue trends, recurring growth, new product launches, and future outlook.

The global critical care diagnostics market is set to witness a growth rate of 6% in the next 5 years. Increasing prevalence ...

The new cytometry technology enhances accessibility, safety, and efficiency in sperm-sorting procedures The acquisition of 18 cell-sorting systems and associated patents positions NewGen for U.S. expa ...

The Uppsala University spinout aims to use its SuperRCA mutation detection technology for applications including molecular residual disease monitoring.

The new cytometry technology enhances accessibility, safety, and efficiency in sperm-sorting procedures The acquisition of 18 cell-sorting systems and associated patents positions NewGen for U.S.

The global cell analyzer market is projected to grow at a CAGR of 8% from 2025 to 2030, driven by the rising prevalence of ...

Stock Market News From July 24, 2025: S&P 500, Nasdaq Set New Closing Highs The Dow edged lower thanks to big drops in IBM, Honeywell, and UnitedHealth.

2025 half-year results Operational performance in line with expectationsPositive cash flow in a context of falling market prices and risi ...

Flow Cytometry's growth accelerates as immuno-oncology and liquid biopsy markets expand, driving cancer research investment. Explore advancements in single-cell genomics and biotech opportunities in ...